We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

179 hedge funds and large institutions have $888M invested in Ariad Pharmaceuticals Inc in 2014 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 49 increasing their positions, 50 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 22

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

36% more capital invested

Capital invested by funds: $655M → $888M (+$233M)

6% more funds holding

Funds holding: 169 → 179 (+10)

2% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 50

8% less call options, than puts

Call options by funds: $32M | Put options by funds: $34.7M

Holders
179
Holders Change
+10
Holders Change %
+5.92%
% of All Funds
4.77%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.16%
New
34
Increased
49
Reduced
50
Closed
22
Calls
$32M
Puts
$34.7M
Net Calls
-$2.74M
Net Calls Change
+$3.27M

Top Buyers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$52M
2
PI
Putnam Investments
Massachusetts
+$18.8M
3
PC
PointState Capital
New York
+$10.3M
4
CCM
Camber Capital Management
Massachusetts
+$9.38M
5
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
+$8.63M

Top Sellers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
-$12.8M
2
Millennium Management
Millennium Management
New York
-$8.89M
3
DFO
Duquesne Family Office
New York
-$8.88M
4
JP Morgan Chase
JP Morgan Chase
New York
-$6.85M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$6.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCMH
151
Cornerstone Capital Management Holdings
New York
$24K +$13.8K +2,200 +169%
RAM
152
Riggs Asset Management
Pennsylvania
$23K – – –
Schroder Investment Management Group
153
Schroder Investment Management Group
United Kingdom
$21K – – –
CPA
154
Cowen Prime Advisors
New York
$13K – – –
RFC
155
Russell Frank Company
Washington
$12K – – –
Fifth Third Bancorp
156
Fifth Third Bancorp
Ohio
$10K – – –
OIA
157
Optimum Investment Advisors
Illinois
$10K – – –
MFS
158
MSI Financial Services
Massachusetts
$9K +$6.25K +1,000 +286%
MCM
159
Manchester Capital Management
Vermont
$7K – – –
PO
160
Private Ocean
California
$7K – – –
Dimensional Fund Advisors
161
Dimensional Fund Advisors
Texas
$6K -$5K -800 -47%
CTC
162
Central Trust Company
Missouri
$5K +$4.38K +700 New
RC
163
RegentAtlantic Capital
New Jersey
$4.12K +$3.75K +600 New
TCOV
164
Trust Company of Vermont
Vermont
$4K – – –
BRWM
165
B. Riley Wealth Management
Tennessee
$3K – – –
KT
166
Kanaly Trust
Texas
$3K – – –
SAM
167
Shamrock Asset Management
Texas
$3K – – –
HNB
168
Huntington National Bank
Ohio
$3K +$2.5K +400 New
TRCT
169
Tower Research Capital (TRC)
New York
$3K +$3.13K +500 New
CG
170
Colony Group
Massachusetts
$2K – – –
DADC
171
D.A. Davidson & Co
Montana
$2K – – –
EFSCE
172
Enterprise Financial Services Corp (EFSC)
Missouri
$2K +$1.69K +270 New
RFA
173
Reilly Financial Advisors
California
$2K +$1.88K +300 New
AA
174
AlphaMark Advisors
Kentucky
$1K – – –
MAA
175
Managed Account Advisors
New Jersey
$1K +$1.32K +211 New
4 5 6
7
8

ARIA Hedge Fund Activity: Q4 2014 in Review

179 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q4 2014, worth a combined $888M — up 36% from $655M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ARIA positions and 22 closed out — a net gain of 12 holders — while 49 added to existing stakes and 50 trimmed.

The largest buyer was Westfield Capital Management, opening a new position worth an estimated $52M. The largest seller was HealthCor Management, exiting entirely with an estimated $12.8M sold.

  • 179 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q4 2014, up from 169 in Q3 2014.
  • Funds reported $888M of Ariad Pharmaceuticals Inc stock for Q4 2014, up 36% quarter-over-quarter.
  • 34 funds opened new Ariad Pharmaceuticals Inc positions in Q4 2014 and 22 closed out, a net change of +12 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q4 2014 was Westfield Capital Management, an estimated $52M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q4 2014 was HealthCor Management, an estimated $12.8M sold.

Based on aggregated 13F filings for Q4 2014.